Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: GeneScience Pharmaceutical Company
Penalty: $7,500,000
Year: 2010
Date: October 6, 2010
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Violation Description: A Chinese drug manufacturer and its CEO pleaded guilty to illegally marketing human growth hormone in the U.S. They jointly forfeited $4.5 million as a result of the criminal charges and agreed to pay an additional $3,000,000 to finance a Clean Competition Fund designed to counter the effects of illicit doping in sports.
Level of Government: federal
Action Type: agency action
Agency: U.S. Attorney-District of Rhode Island
Civil or Criminal Case: criminal
Source of Data: (click here)
Archived Source: (click here)
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.